A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Location: United States, Massachusetts, Boston
Investors 1
| Date | Name | Website |
| - | Diamond Bi... | diamondbio... |